Conversant Bio Overview
- Founded
- 2006

- Status
- Acquired/Merged
- Latest Deal Type
- Merger of Eq.
- Financing Rounds
- 1
- Investments
- 2
Conversant Bio General Information
Description
Provider of biospecimen services intended for oncology and rheumatology research. The company's services including procurement of human primary cells from peripheral blood, bone marrow, processed and whole tissue as well as assessment of tumor tissues for scientific investigations, enable clients to develop new medicines and diagnostic tools.
Contact Information
- 601 Genome Way
- Suite 1200
- Huntsville, AL 35806
- United States
Conversant Bio Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Conversant Bio‘s full profile, request access.
Request a free trialConversant Bio Comparisons
Industry
00000000
000000 0
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialConversant Bio Competitors (6)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
StemCell Technologies | Private Equity-Backed | Vancouver, Canada | 0000 | 000.00 | 00000000. 00 | 000.00 |
000000 000000000 0 | Corporation | Glasgow, United Kingdom | ||||
0000 000000000000 | Corporation | San Diego, CA | 0 | 000000000 - | ||
00000000 000000000 | Private Equity-Backed | Lexington, MA | 00 | 000.00 | 000000000000 | |
000000 0000000000 | Private Equity-Backed | Nottingham, United Kingdom | 000 | 000.00 | 00000000 | 000.00 |
Conversant Bio Executive Team (4)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Will Taylor | Chief Financial Officer | ||
Jay Scherer | Chief Operating Officer | ||
Luke Doiron | Co-Founder, Chief Commercial Officer & Board Member |
Conversant Bio Board Members (1)
Name | Representing | Role | Since |
---|---|---|---|
0000 000000 | Conversant Bio | Co-Founder, Chief Commercial Officer & Board Member | 000 0000 |
Conversant Bio Investments (2)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
000000 000000 0000 | 24-Mar-2015 | 00000 | 0000 | Clinics/Outpatient Services | 00000000 000000000 00. |
Entopsis | 18-Mar-2015 | Seed Round | 00000 | Diagnostic Equipment |